Related Experiment Videos
Second-look laparotomy and salvage therapy: a research modality only?
M E Potter1, K D Hatch, S J Soong
1University of Alabama, Birmingham 35294.
Gynecologic Oncology
|January 11, 1992
Summary
Second-look laparotomy in epithelial ovarian cancer did not improve survival with current therapies. It should be reserved for research protocols evaluating new treatments.
Area of Science:
- Gynecology
- Oncology
- Surgical Oncology
Background:
- Epithelial ovarian cancer (EOC) treatment often involves surgery and chemotherapy.
- Second-look laparotomy (SLL) is a surgical procedure to assess residual disease after initial treatment.
- The role of SLL in improving patient outcomes for EOC remains a subject of investigation.
Purpose of the Study:
- To evaluate factors associated with positive SLL findings in EOC patients.
- To determine the impact of SLL on recurrence and survival.
- To assess the efficacy of salvage therapies following SLL.
Main Methods:
- Retrospective analysis of 212 patients with EOC who underwent SLL.
- Evaluation of factors including initial stage, tumor grade, age, residual disease, and adjuvant therapy.
- Comparison of survival rates based on SLL results and salvage treatment modalities.
Main Results:
- Positive SLL findings were associated with initial stage, tumor grade, age, and residual disease (P < 0.05).
- Initial stage was the only factor linked to recurrence after a negative SLL (P < 0.001).
- No significant survival difference was observed between patients with recurrence after negative SLL and those with microscopic residual disease.
Conclusions:
- Second-look laparotomy does not enhance survival with existing salvage therapies for EOC.
- SLL should primarily be considered for patients enrolled in research protocols for novel second-line therapies.
- Current evidence suggests SLL's utility is limited outside of clinical trials for EOC.